David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Houston topical foam trialists wanted

Written by on September 25, 2017 in clinical trials with 0 Comments
Houston topical foam trialists wanted

[Sponsored Post] Are you having problems with Rosacea? The Center for Clinical Studies is looking for volunteers, age 18 and over that have been diagnosed with Rosacea to participate in a clinical research study for an investigational foam. To qualify you must: Be age 18 or older Have moderate-to- severe rosacea  Willing to minimize external factors […]

Continue Reading

The BIG Questions in Rosacea

Written by on September 25, 2017 in research, What Causes Rosacea? with 2 Comments
The BIG Questions in Rosacea

  Want to do some research in rosacea and stuck for a suggestion? Well this post is for you. Below is a list of the major open questions in rosacea research. The creator of this list tells us that this list of questions need to be answered before we can claim to thoroughly understand rosacea. […]

Continue Reading

Rosacea Phenotypes Explained

Written by on September 24, 2017 in Rosacea Symptoms, What Causes Rosacea? with 0 Comments
Rosacea Phenotypes Explained

  (click for larger image) You may have missed it, but the new way to diagnose rosacea is based on phenotypes. Yes, we no longer talk about rosacea sub-types but refer to the phenotypes of rosacea. Here is everything you need to know about this new way of describing rosacea symptoms. Lets start with a […]

Continue Reading

Stanford wants Secukinumab trialists

Written by on August 5, 2017 in clinical trials, research with 0 Comments

A clinical trial at Stanford Dermatology is seeking trialists to join a study looking at Secukinumab as a treatment for the papules and pustules, and redness associated with rosacea. If you are interested, and meet the requirements for the trial, please contact them via their details below. What is Secukinumab? Secukinumab (brand name Cosentyx) has recently become […]

Continue Reading

Rhofade scores a mention in The New York Times

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy. How to Go Makeup-Free This Summer By CRYSTAL MARTIN AUG. 1, […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.